| Not Yet Recruiting | A Study of the Effect of a Nurse Navigator Program on High Risk Patients NCT05592847 | Mayo Clinic | N/A |
| Not Yet Recruiting | Hypoxia and Heart Rate Variability NCT05606406 | University of Miami | N/A |
| Not Yet Recruiting | Functional Assessment and Pulmonary Rehabilitation: Challenges and Perspectives for Comprehensive Care NCT07415746 | Universidade do Estado do Pará | N/A |
| Active Not Recruiting | A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder NCT07252908 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 2 |
| Recruiting | eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Di NCT07177339 | GlaxoSmithKline | Phase 3 |
| Recruiting | Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (C NCT06961214 | GlaxoSmithKline | Phase 3 |
| Recruiting | Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (C NCT06959095 | GlaxoSmithKline | Phase 3 |
| Recruiting | Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave NCT06890208 | Universitätsklinikum Hamburg-Eppendorf | — |
| Not Yet Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK386 NCT06979518 | GlaxoSmithKline | Phase 1 |
| Recruiting | Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting NCT06712563 | AstraZeneca | — |
| Recruiting | The Effect of Gait Training Using Different Slope Types on Balance in COPD Patients NCT06644898 | Acibadem University | N/A |
| Recruiting | Investigation of Walking Training With Different Slope Types in COPD Patients NCT06283004 | Acibadem University | N/A |
| Not Yet Recruiting | Early Screening of Young COPD and Pre-COPD NCT06844175 | yanmengkang | — |
| Recruiting | Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity NCT06831994 | Universitätsklinikum Hamburg-Eppendorf | N/A |
| Recruiting | Detecting Systemic Carbon Dioxide Levels With a Novel Biosensor NCT06367686 | The Hospital of Vestfold | — |
| Recruiting | The ROAM Research Study Therapy (LTOT) Version NCT06810323 | University of Virginia | — |
| Not Yet Recruiting | Benefits of Epithelial Repair in COPD by Induced Pluripotent Stem Cells (iPS) NCT06755008 | University Hospital, Montpellier | N/A |
| Not Yet Recruiting | Efficacy of Self-titration of Ventilation in Overlap Syndrome (chronic Obstructive Pulmonar Disease + Sleep Ap NCT06713486 | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | N/A |
| Completed | A Study to Evaluate the Effect of Itraconazole on the Concentration of GSK3923868 in the Blood in Healthy Part NCT06597500 | GlaxoSmithKline | Phase 1 |
| Completed | A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive NCT06527144 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 2 |
| Completed | EXACERBATIONS AND REAL-WORLD OUTOMES AMONG PATIENTS WITH COPD INITIATING BREZTRI (EROS+CP Japan Study) NCT07103642 | AstraZeneca | — |
| Withdrawn | Extracorporeal CO2 Removal for Acute Decompensation of COPD NCT04582799 | University of Bologna | N/A |
| Not Yet Recruiting | Determination of Factors Effecting Falls in Patients With COPD NCT06483776 | Hacettepe University | — |
| Completed | Changes in Dyspnea, Activity and Sleep in COPD by Video-Based Breathing Exercises NCT06477367 | Bartın Unıversity | N/A |
| Completed | EXACERBATIONS AND REAL-WORLD OUTOMES INCLUDING CARDIOPULMONARY EVENTS AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE NCT06742736 | AstraZeneca | — |
| Completed | Chronical Illness-related Limitations of the Ability to Cope with Rising Temperatures: an Observational Study, NCT06407154 | Universitätsklinikum Hamburg-Eppendorf | — |
| Withdrawn | UM CRMC RecuR Score Pilot NCT05765903 | University of Maryland, Baltimore | N/A |
| Completed | PEP Buddy Impact on Breathing, Exercise, and Sleep Quality in COPD Patients NCT06290245 | Cairo University | N/A |
| Unknown | Determination of Body Awareness and the Functional Movement in Patients With COPD NCT06298994 | Hacettepe University | — |
| Completed | A Comparative Effectiveness Study of Mortality Outcomes and Related Cardiopulmonary Events Among a Cohort of C NCT06744374 | AstraZeneca | — |
| Enrolling By Invitation | Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study NCT07363980 | Ellen Margrethe Hauge | — |
| Completed | Impact of COPD on Sexual Health, Loneliness, and Well-being NCT06240078 | Vejle Hospital | — |
| Unknown | Task-specific Training for Patients With Acute Exacerbation of COPD NCT06224075 | Universidad de Granada | N/A |
| Completed | Evaluation of 611 in Chinese Adults With Moderate to Severe Chronic Obstructive Pulmonary Disease NCT06099652 | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Phase 2 |
| Recruiting | A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease NCT06154837 | GlaxoSmithKline | Phase 1 |
| Completed | RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection NCT06149494 | Altesa Biosciences, Inc. | Phase 2 |
| Unknown | Exercise Tolerance and Lower-limb Muscle Power in Patients With Chronic Respiratory Disease NCT06124859 | Lille Catholic University | N/A |
| Unknown | Development and Feasibility Testing of Digital Theory-based Pursed Lip Breathing in Stable Patients With COPD NCT06063733 | Manchester Metropolitan University | N/A |
| Completed | Digital Tool Enhancing GPs' Information Management for Patients with Multimorbidity - a Pilot Study NCT06061172 | Universitätsklinikum Hamburg-Eppendorf | N/A |
| Unknown | High Intensity Interval Training and Muscle Adaptations During PR NCT05858463 | University Hospital, Clermont-Ferrand | N/A |
| Completed | Diagnosing Obstructive Lung Disease With Point of Care Ultrasound NCT06251271 | Soroka University Medical Center | — |
| Terminated | Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study NCT05961163 | Universitätsklinikum Hamburg-Eppendorf | — |
| Withdrawn | TOBacco STOP in Chronic Obstructive Pulmonary Disease-Trial - Study Protocol NCT04088942 | Pradeesh Sivapalan | Phase 4 |
| Completed | A Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in NCT04923347 | GlaxoSmithKline | Phase 4 |
| Recruiting | Trial to Determine Effective Aspirin Dose in COPD NCT05265299 | Johns Hopkins University | Phase 3 |
| Recruiting | Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD NCT05718102 | Seattle Institute for Biomedical and Clinical Research | N/A |
| Recruiting | Prediction of COPD Severity Using Electrical Impedance Tomography NCT06359145 | Chinese PLA General Hospital | — |
| Recruiting | Deep Learning Diagnostic and Risk-stratification for IPF and COPD NCT05318599 | Pediatric Clinical Research Platform | — |
| Completed | Does Severity of Airflow Obstruction Correlate to Static Lung Volumes NCT05616780 | Virginia Hawkins | N/A |
| Unknown | Respiratory Rate Validation Study - HiCardi+ Wearable Patch Device, Mezoo Co., Ltd. NCT05863091 | Yonsei University | N/A |
| Terminated | Treatment Efficacy of Systemic Corticosteroids in AECOPD Patients With Higher Blood Eosinophil Levels NCT05059873 | Capital Medical University | Phase 4 |
| Recruiting | Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations NCT05704881 | University Hospital, Grenoble | — |
| Recruiting | Neuromuscular Fatigue During Exercise in COPD-HF Overlap NCT05235685 | University Hospital, Grenoble | N/A |
| Recruiting | Reducing the Number of Hospital Admissions With Multiple Nursing Interventions in COPD Patients Using Oxygen C NCT05730088 | Necmettin Erbakan University | N/A |
| Completed | Phase 1, Single and Repeat Dose Study to Assess Safety, Tolerability, and Pharmacokinetics (PK) of GSK3923868 NCT05677347 | GlaxoSmithKline | Phase 1 |
| Active Not Recruiting | Air Filtration for COPD in VA Population of Veterans NCT05913765 | Illinois Institute of Technology | N/A |
| Unknown | The Effect of Aromatherapy Massage on Pain, Anxiety and Comfort NCT06295874 | Nilgün Erdoğan | N/A |
| Completed | A Study to Investigate the Association of Real-world Sensor-derived Biometric Data With Clinical Parameters an NCT05655832 | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | N/A |
| Completed | Breathing With a Facemask Exercise Performance NCT05633017 | CereVu Medical, Inc. | — |
| Completed | Involvement of Skeletal Muscle Fibrocytes in sarcOpenia in Patients With Chronic ObstRuctive Pulmonary Disease NCT04939454 | University Hospital, Bordeaux | N/A |
| Completed | To Evaluate Real-World Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol (FF/UMEC/VI) in a NCT05535972 | GlaxoSmithKline | Phase 4 |
| Completed | Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) NCT05402020 | Boehringer Ingelheim | — |
| Completed | Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-in NCT05393245 | Boehringer Ingelheim | — |
| Not Yet Recruiting | Antibiotic Stewardship in AECOPD Through CRP-Guided Management NCT05286918 | The University of Hong Kong | N/A |
| Terminated | Assessment of Health-related Quality of Life After Switching COPD Patients From a Dry Powder Inhaler to a Soft NCT05362487 | Boehringer Ingelheim | — |
| Completed | (In)Voluntary Assessed Quadriceps Muscle Endurance in COPD NCT05427773 | Radboud University Medical Center | — |
| Unknown | Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions NCT05330507 | Convexity Scientific Inc | — |
| Completed | Efficacy and Safety of GSK3923868 Inhalation Powder, During Experimental Human Rhinovirus Infection in Partici NCT05398198 | GlaxoSmithKline | Phase 1 |
| Completed | Change in Symptom and Quality of Life in COPD by Budesonide/Glycopyrronium/Formoterol Fumarate Pressurized Met NCT05219630 | AstraZeneca | — |
| Active Not Recruiting | A Multicenter, Prospective Trial of the IAB in Adults Suffering From COPD/Emphysema NCT05087641 | Pulmair Medical, Inc. | N/A |
| Active Not Recruiting | Development and Validation of the GLORI-COPD Score NCT04027296 | University of Paris 5 - Rene Descartes | — |
| Withdrawn | Pilot Study: Post-Recovery LibEration From Oxygen in Exacerbated COPD NCT04854967 | VA Office of Research and Development | N/A |
| Unknown | Changes in Heart Rate Variability And Heart Rate/Activity Slope After Hospitalization for Acute Exacerbations NCT05290831 | Minneapolis Veterans Affairs Medical Center | N/A |
| Unknown | The Effect of Mobile Health Applications on Symptom Control, Self-efficacy and Chronic Disease Management in C NCT05295901 | Muş Alparslan University | N/A |
| Completed | Digihaler in Chronic Obstructive Pulmonary Disease (COPD) NCT05241288 | University of North Carolina, Chapel Hill | N/A |
| Completed | COPD E-cigarette Topography Training NCT05510154 | University of Kansas Medical Center | N/A |
| Completed | Cognitive and Physical Training in Patients With Chronic Obstructive Pulmonary Disease Patients NCT05140226 | University Health Network, Toronto | N/A |
| Completed | COVID-19, Patients' Evolution and the Influence of the Pandemic on Health Care and Outcomes in Chronic Disease NCT05168722 | Hospital Galdakao-Usansolo | — |
| Completed | Effects of Tai Chi for Early Pulmonary Rehabilitation in Elderly Patients With AECOPD NCT05986448 | Houmei SHEN | N/A |
| Unknown | Social Media-based Bundle Care of AECOPD Patients. NCT05209607 | Beijing Chao Yang Hospital | Phase 4 |
| Completed | REal-time Data Monitoring for Shared Adaptive, Multi-domain and Personalised Prediction and Decision Making fo NCT04955080 | Medisch Spectrum Twente | — |
| Unknown | Staphylococcus and Neisseria Tablets in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary NCT05543343 | Qu Yiqing | N/A |
| Unknown | Physical Exercise and Responses Measured by HIF-1 in COPD NCT04955977 | Universidad Nacional de Colombia | N/A |
| Completed | The Effect of Education Based on the Chronic Care Model in COPD Patients NCT05029557 | Hasan Kalyoncu University | N/A |
| Completed | A Study in the US Based on Pharmacy and Medical Claims That Compares How Well Stiolto® and Trelegy® Work in Pe NCT05169424 | Boehringer Ingelheim | — |
| Unknown | Sputum Colour Charts to Guide Antibiotic Self-treatment of Acute Exacerbation of COPD (Colour COPD) NCT04705233 | University of Birmingham | N/A |
| Completed | BREATHE ALD: A Shared Decision-Making Intervention for Adults With Advanced Lung Disease NCT04930666 | Columbia University | — |
| Withdrawn | Tiotropium Plus Olodaterol vs Inhaled Corticosteroids (ICS) Regimens in the Portuguese Primary Care Setting (T NCT04402515 | Boehringer Ingelheim | — |
| Completed | Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD NCT04882124 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Explore the Sharing Model Intervene to Improve the Knowledge, Attitudes, Service Intentions and Service Start- NCT05407272 | Wen-Shiou Pan | N/A |
| Completed | Physical Capacity of Patients With Chronic Obstructive Pulmonary Disease With and Without Supplementation of W NCT03386604 | Hospital de Clinicas de Porto Alegre | N/A |
| Completed | The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD NCT05043428 | McGill University | N/A |
| Unknown | Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II NCT05032898 | China-Japan Friendship Hospital | — |
| Active Not Recruiting | Evaluating the Clinical Effectiveness of a Patient-specific Silicone Stent NCT05050591 | VisionAir Solutions | N/A |
| Completed | Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial NCT04283994 | University of Washington | N/A |
| Completed | First-in-human Clinical Trial Evaluating CUR-N399 in Healthy Volunteers. NCT05016687 | Curovir AB | Phase 1 |
| Unknown | Internet-based Rehabilitation Aftercare Focusing on Physical Activity Promotion in Persons With COPD NCT05006560 | University of Erlangen-Nürnberg | N/A |
| Completed | Effects of Acute Long-acting Bronchodilation on Oxygenation and Peripheral Ventilation in COPD NCT05927155 | Erasme University Hospital | Phase 3 |
| Completed | A Pulmonary Rehabilitation Shared Decision Making Intervention NCT04990180 | University Hospitals, Leicester | N/A |
| Completed | Chronic Obstructive Pulmonary Disease (COPD) Maintenance Treatment Patterns in China NCT04853238 | GlaxoSmithKline | — |
| Completed | Proof of Concept Study Assessing Technology-Assisted Respiratory Adherence Prototype Version 3 in Individuals NCT04795323 | Boehringer Ingelheim | Phase 2 |
| Completed | Impact of Primary Care COPD Screening Strategies on the Smoking Cessation Process (DISCO-SET) NCT04833933 | Rennes University Hospital | — |
| Completed | Morbid Rates After Spiriva Chronic Obstructive Pulmonary Disease (COPD) Protocol Change NCT06053541 | Boehringer Ingelheim | — |
| Completed | A Study Using US Medical and Pharmacy Claim Records to Compare the Resource Use, Cost, and Outcomes of People NCT05127304 | Boehringer Ingelheim | — |
| Completed | HHHFA in COPD Patients, With Chronic Bronchitis NCT03959982 | Spyridon Fortis | N/A |
| Unknown | Influence of Regular Physical Activity on Sleep in Patients With COPD and Idiopathic Lung Fibrosis NCT05087017 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | — |
| Withdrawn | TARA Working Prototype [Version 2]: Feasibility Study NCT04320524 | Boehringer Ingelheim | N/A |
| Completed | Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients After Switching to Tiotropium Plus Ol NCT04672941 | Boehringer Ingelheim | — |
| Unknown | The Prescriptive Validity of a Novel Fall Risk Clinical Prediction Rule for People With COPD NCT05173532 | Texas Woman's University | N/A |
| Completed | Enhancing Exercise Training for Adults With COPD NCT04704310 | McGill University | N/A |
| Completed | Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) Participants NCT04657211 | GlaxoSmithKline | — |
| Completed | A Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Participants With Moderate to S NCT04647383 | Eisai Inc. | Phase 1 |
| Unknown | The Effects of Inhaled Budesonide-formoterol-glycopyrronium in Moderate-to-severe COPD NCT04675463 | ShiYue Li | N/A |
| Completed | Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest NCT04170062 | Johns Hopkins University | N/A |
| Completed | Study of Relationship Between Changes in Inflammation, Lung Function, Symptoms and Medication Use in COPD Pati NCT04168216 | AstraZeneca | — |
| Completed | An Atlas of Airways at a Single Cell Level in Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibr NCT04529993 | Centre Hospitalier Universitaire de Nice | N/A |
| Unknown | Remote Prescribed and Monitored Exercise Program After Pulmonary Rehabilitation in Individuals With Chronic Lu NCT04599387 | Sheba Medical Center | N/A |
| Completed | Clinical Phenotypes of COPD Patients Between in Plateau and Plain NCT04964076 | Peking University Third Hospital | — |
| Completed | Safety, Tolerability and Pharmacokinetics of GSK3923868 Inhalation Powder in Healthy Participants and Stable A NCT04585009 | GlaxoSmithKline | Phase 1 |
| Completed | The Impact of a Home-based Pulmonary Telerehabilitation Program in Acute Exacerbations of COPD NCT03997513 | VA Office of Research and Development | N/A |
| Completed | Electronic Proactive Outreach for Smokers With COPD NCT04462289 | VA Office of Research and Development | N/A |
| Completed | The Use of Wearable Technology to Acquire Signals for COPD Research NCT04495062 | Royal Free Hospital NHS Foundation Trust | — |
| Completed | Assessing Adherence to Home Telemedicine in Individuals With Chronic Obstructive Pulmonary Disease (COPD) NCT04369885 | University of North Carolina, Chapel Hill | N/A |
| Completed | An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI NCT04717492 | University of Minnesota | — |
| Unknown | Improvement of Cardiovascular Function After Bronchoscopic Lung Volume Reduction Using Endobronchial Valves NCT04556942 | Daniel Franzen | N/A |
| Completed | A Study of Smoking Cessation Patterns in Participants Undergoing Lung Surgery NCT04313361 | Johnson & Johnson (China) Investment Ltd. | — |
| Completed | Management and Healthcare Utilization of Patients With Chronic Airway Disease During the COVID-19 Epidemic NCT04948216 | Peking University Third Hospital | — |
| Completed | Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1) NCT04281784 | University of Washington | N/A |
| Completed | Investigation of Chronic Obstructive Pulmonary Disease (COPD) Phenotypes and Endotypes in China NCT04853225 | GlaxoSmithKline | — |
| Completed | A Study in South Korea Using Medical Records to Look at Different Treatments for Chronic Obstructive Airway Di NCT04172701 | Boehringer Ingelheim | — |
| Unknown | Analysis of the Microbiome in the Healthy Smokers and COPD Patients NCT04336423 | Asan Medical Center | — |
| Completed | Early Intervention Efficacy in COPD NCT04249310 | Boehringer Ingelheim | — |
| Recruiting | Targeted Nutrient Supplement in COPD (NUTRECOVER-trial) NCT03807310 | Maastricht University Medical Center | N/A |
| Active Not Recruiting | Short Arm Human Centrifuge Therapeutic Training and Rehabilitation (GRACER1) NCT04369976 | Greek Aerospace Medical Association and Space Research | N/A |
| Unknown | Compliance With Clinical Guidelines and Effect on Patient Outcome of Treatment of Hospitalised Exacerbations o NCT04237896 | Sociedad Española De Medicina Interna | — |
| Completed | A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler in People With Chroni NCT04223843 | Boehringer Ingelheim | Phase 4 |
| Completed | A Study in Taiwan Based on Medical Records That Looks at the Occurrence of Flare-ups in Patients With Chronic NCT04011475 | Boehringer Ingelheim | — |
| Completed | E-Visit for COPD and Smoking Cessation NCT04155073 | Medical University of South Carolina | N/A |
| Completed | A Study on Whether Patients Prefer the Spiriva® Respimat® or the Spiriva® Handihaler® for Treating Their Chron NCT03964207 | Boehringer Ingelheim | Phase 4 |
| Completed | A Study Based on Health Insurance Data About the Treatment of Patients Who Have Been Newly Diagnosed With Chro NCT04097223 | Boehringer Ingelheim | — |
| Completed | Characteristics and Treatment Patterns of Patients With Chronic Obstructive Pulmonary Disease (COPD), Initiati NCT04926233 | Boehringer Ingelheim | — |
| Unknown | Effects of Pulmonary Rehabilitation on Walking Speed in Patients With COPD or ILD Patients NCT04159129 | Schön Klinik Berchtesgadener Land | — |
| Completed | Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to Triple Therapy NCT04184297 | Boehringer Ingelheim | — |
| Completed | Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinoph NCT04133909 | GlaxoSmithKline | Phase 3 |
| Completed | Mobile-Application Based Respiratory Rehabilitation For COPD NCT05890443 | Ordu University | N/A |
| Completed | Re-usable Respimat® Soft MistTM Inhaler Study NCT04011735 | Boehringer Ingelheim | — |
| Completed | TARA Working Prototype Engagement Evaluation: Feasibility Study NCT04085302 | Boehringer Ingelheim | N/A |
| Completed | Dose-range Finding Efficacy and Safety Study for QBW251 in COPD Patients NCT04072887 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Respiratory Drive Response in COPD Patients During Exercise With Non Invasive Ventilation (NIV). NCT04597606 | Javier Sayas Catalan | — |
| Completed | Smartphone-App as Maintenance Program in COPD NCT04299165 | Kaia Health Software | N/A |
| Completed | Effects of SIMEOX on Static Hyperinflation in Patients With COPD NCT04157972 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | N/A |
| Completed | Effects of SIMEOX on Flow and Volume in Healthy Subjects and Patients With COPD NCT04150601 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | N/A |
| Completed | The COPD Attack Study NCT05779384 | Makerere University | — |
| Completed | A Wearable and a Self-management Application for Chronic Obstructive Pulmonary Disease (COPD) Patients at Home NCT03857061 | University Health Network, Toronto | — |
| Withdrawn | Legend: TRELEGY Real World Chronic Obstructive Pulmonary Disease (COPD) Effectiveness Study NCT03949842 | GlaxoSmithKline | Phase 4 |
| Terminated | Ciliation and Mucus Rheology Parameters Determined Via Air-liquid-interface Cell Cultures in Non-smoking, Smok NCT03187860 | University Hospital, Montpellier | N/A |
| Completed | Etiology of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) in Japan NCT03957577 | GlaxoSmithKline | — |
| Completed | A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Med NCT03979807 | Boehringer Ingelheim | — |
| Completed | Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Pr NCT03954132 | Boehringer Ingelheim | — |
| Completed | Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Eosinophilia Among Primary Care Patients NCT03018808 | GlaxoSmithKline | — |
| Unknown | Mechanisms of COPD Exacerbation Recurrence NCT04024735 | University College, London | — |
| Terminated | NIV for COPD: Hospital to Home NCT04413643 | San Francisco Veterans Affairs Medical Center | N/A |
| Completed | Facilitating Communication Study NCT03721952 | University of Washington | N/A |
| Completed | CT-Based Modeling of Bone Micro-Architecture and Fracture-Risk in COPD NCT03534934 | Punam K Saha | N/A |
| Unknown | Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exerci NCT03718780 | Centre Hospitalier Metropole Savoie | N/A |
| Completed | Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness in Patients With Advanced NCT04630743 | University of Cologne | N/A |
| Completed | Mortality and Symptom Burden Post Hospitalisation With COPD NCT03657121 | Northumbria Healthcare NHS Foundation Trust | — |
| Withdrawn | Testing Cognitive Functions in Patients With COPD Using a Driving Simulator NCT02740673 | Aarhus University Hospital | N/A |
| Unknown | Severe Chronic Respiratory Failure and Citrulline NCT03694964 | University Hospital, Grenoble | N/A |
| Completed | Study Evaluating 5 Doses of RPL554 and Placebo in COPD Patients Via a Dry Powder Inhaler NCT04027439 | Verona Pharma plc | Phase 2 |
| Unknown | The Microbiome of Sputum, Urine and Feces in Healthy Persons and Chronic Obstructive Pulmonary Disease (COPD) NCT03755505 | Asan Medical Center | — |
| Completed | Sprint Interval Training in Patients With Chronic Obstructive Lung Disease NCT03735615 | Norwegian University of Science and Technology | N/A |
| Completed | Increase Level of Physical Activity and Decrease Use of Health Care for People With COPD NCT03746873 | Umeå University | N/A |
| Terminated | Inhaled Long-acting Bronchodilators With or Without Inhaled Glucocorticosteroids for Preventing Hospitalizatio NCT03662711 | Università degli Studi di Ferrara | Phase 4 |
| Completed | Effectiveness of Triple Therapy in COPD NCT03724877 | Boehringer Ingelheim | — |
| Unknown | Abnormal Pain Processing in COPD Patients NCT04319523 | Universidad de Granada | — |
| Completed | Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pil NCT03691324 | Oslo University College | N/A |
| Completed | The Study for Evaluating Factors Relating to Daily Step Counts and Physical Activity in Japanese Patients With NCT03642613 | AstraZeneca | — |
| Completed | A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate NCT03740373 | AstraZeneca | Phase 1 |
| Completed | A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of T NCT03663569 | Boehringer Ingelheim | — |
| Completed | The OPTI Study in Spain Looks at the History Flare-ups in Patients With Chronic Obstructive Pulmonary Disease NCT03611777 | Boehringer Ingelheim | — |
| Completed | Sensor and Electronic Health Records (EHR) Integration Pilot Study NCT03357341 | GlaxoSmithKline | — |
| Recruiting | Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD NCT02655302 | University Hospital, Lille | N/A |
| Completed | Efficacy of Acupuncture in Exercise Tolerance in Patients With COPD NCT03767140 | Instituto de Ciências Biomédicas Abel Salazar | N/A |
| Completed | High-Flow Nasal Oxygen Therapy for Exacerbation of Chronic Pulmonary Obstructive Disease. NCT03488628 | Centre Hospitalier Régional d'Orléans | N/A |
| Completed | A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple NCT03478696 | GlaxoSmithKline | Phase 4 |
| Completed | A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple T NCT03478683 | GlaxoSmithKline | Phase 4 |
| Unknown | Differences of Small Airways Function Between Chronic Obstructive Pulmonary Disease(COPD) and Asthma-copd Over NCT03563001 | Zhujiang Hospital | Phase 4 |
| Unknown | Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPD NCT03745261 | Henan University of Traditional Chinese Medicine | Phase 3 |
| Completed | A Prospective Cohort Study of Asthma and COPD Overlap in Japanese COPD Patients Using the Diagnostic Criteria NCT03577795 | AstraZeneca | — |
| Unknown | Change of Lung Function After Exercise in Patients With Chronic Obstructive Pulmonary Disease NCT03551197 | Zhujiang Hospital | Phase 4 |
| Completed | Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness NCT03543176 | GlaxoSmithKline | — |
| Withdrawn | Does Pulmonary Rehabilitation Improve Breathing of COPD Patients NCT01815970 | University of British Columbia | N/A |
| Completed | Use of Diagnostic Measures in Chronic Obstructive Pulmonary Disease (COPD) in Routine Practice and Their Impac NCT03465332 | GlaxoSmithKline | — |
| Completed | INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design NCT03467425 | GlaxoSmithKline | Phase 4 |
| Completed | Calprotectin I Serum as a Diagnostic Marker NCT03474484 | St. Olavs Hospital | — |
| Unknown | Acupoint Transcutaneous Electrical Nerve Stimulation in Hospitalized COPD Patients With Severe Dyspnoea NCT02998957 | Fundació Sant Joan de Déu | N/A |
| Completed | A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple The NCT03474081 | GlaxoSmithKline | Phase 4 |
| Terminated | Study of Automated Care Pathway for Patients With Chronic Obstructive Pulmonary Disease (COPD) NCT03028805 | University of California, San Francisco | N/A |
| Completed | Greek NIS Spiolto ELLACTO NCT03419962 | Boehringer Ingelheim | — |
| Completed | GSK1325756 Relative Bioavailability Study in Healthy Elderly Subjects NCT03457727 | GlaxoSmithKline | Phase 1 |
| Unknown | Effects of Traditional Chinese Medicine on AECOPD Patients NCT03428412 | Henan University of Traditional Chinese Medicine | Phase 3 |
| Unknown | Feasibility and Effect of a Follow up Tele-rehabilitation Program for Chronic Obstructive Lung Disease vs. Sta NCT03443817 | University of Aarhus | N/A |
| Terminated | Mapping Sound Propagation Through the Human Lung for Better Diagnosis NCT03043898 | Maximilian Nussbaumer | — |
| Unknown | Bayis Ilh Tus - A Strong Breath: Prevalence and Contributors to COPD in First Nations Communities in British C NCT04105088 | University of British Columbia | — |
| Completed | Peripheral Nerve Blocks for Above-the-knee Amputations NCT03404180 | University of Florida | Phase 4 |
| Completed | Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-ac NCT03405363 | Boehringer Ingelheim | — |
| Recruiting | Oscillating Positive Expiratory Pressure Devices and Acute Exacerbation of Chronic Obstructive Pulmonary Disea NCT03299231 | Ain Shams University | N/A |
| Completed | A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics (PK) of Nemiralisib NCT03398421 | GlaxoSmithKline | Phase 1 |
| Completed | Effects of Liraglutide in Chronic Obstructive Pulmonary Disease NCT03466021 | Claus Bogh Juhl | Phase 4 |
| Completed | Сohort Study to Evaluate Exacerbations, Respiratory Symptoms, Physical Exercise Intolerance and Lung Functions NCT03383601 | Kazakhstan Academy of Preventive Medicine | — |
| Completed | Burden of Disease Among Subjects With Eosinophilic Chronic Obstructive Pulmonary Disease (COPD) NCT03436511 | GlaxoSmithKline | — |
| Completed | Comparative Effectiveness of COPD Treatments NCT03376295 | Boehringer Ingelheim | — |
| Terminated | Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Ch NCT03345407 | GlaxoSmithKline | Phase 2 |
| Completed | Pharmacokinetics, Safety and Tolerability of Twice-Daily Aclidinium Bromide/Formoterol Fumarate Fixed Dose Com NCT03276078 | AstraZeneca | Phase 2 |
| Terminated | Randomized Study Evaluating the Effect of Danirixin on Neutrophil Extracellular Traps (NETs) in Chronic Obstru NCT03250689 | GlaxoSmithKline | Phase 2 |
| Completed | Absorption & Elimination of Radiolabelled GSK2269557 NCT03315559 | GlaxoSmithKline | Phase 1 |
| Terminated | A Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD) NCT03170232 | GlaxoSmithKline | Phase 2 |
| Withdrawn | Evaluating the Clinical Effectiveness of 3D Printing for a Patient-specific Silicone Stent Airway Implant NCT03111888 | The Cleveland Clinic | N/A |
| Unknown | The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease NCT03075709 | University of Saskatchewan | — |
| Completed | Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combinatio NCT03265145 | Boehringer Ingelheim | Phase 4 |
| Completed | Comparative Study of ELLIPTA Dry Powder Inhaler (DPI) Versus DISKUS DPI Used With HandiHaler DPI in Subjects W NCT03227445 | GlaxoSmithKline | Phase 4 |
| Unknown | The Clinical Application and Popularization of Portable Home Noninvasive Ventilator NCT03238339 | Mingdong Hu | — |
| Completed | Sleep and Daytime Use of Humidified Nasal High-flow Oxygen in COPD Outpatients NCT03221387 | Temple University | N/A |
| Unknown | Dynamic Hyperinflation In Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients NCT03230617 | Assiut University | — |
| Completed | RELVAR® 100 ELLIPTA® Special Drug Use Investigation (COPD, Long-term) NCT03219255 | GlaxoSmithKline | — |
| Completed | The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medic NCT03240575 | Boehringer Ingelheim | Phase 4 |
| Completed | Modeling Bronchial Epithelium Modifications Associated With COPD Using iPS NCT03181204 | University Hospital, Montpellier | — |
| Completed | Study of Safety and Drug Levels of CCI15106 Inhalation Powder in Healthy Adults and Adults With Moderate Chron NCT03235726 | GlaxoSmithKline | Phase 1 |
| Completed | A 24-week Study to Compare Umeclidinium/Vilanterol (UMEC/VI), UMEC and Salmeterol in Subjects With Chronic Obs NCT03034915 | GlaxoSmithKline | Phase 4 |
| Completed | Safety, Tolerability and Pharmacokinetics (PK) Study of GSK2269557 in Healthy Subjects NCT03189589 | GlaxoSmithKline | Phase 1 |
| Completed | Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIs NCT03114969 | GlaxoSmithKline | — |
| Completed | Effectiveness and Handling of Spiolto® Respimat ® in COPD Patients - Italy NCT03003494 | Boehringer Ingelheim | — |
| Completed | Patient Characteristics and Treatment Modalities in COPD Patients in China NCT03161587 | GlaxoSmithKline | — |
| Completed | Changes in Health and Functional Status in Patients With Chronic Obstructive Pulmonary Disease During Therapy NCT03165045 | Boehringer Ingelheim | — |
| Completed | INtervention Study In overweiGHT Patients With COPD NCT02634268 | Seattle Institute for Biomedical and Clinical Research | N/A |
| Completed | Study of Danirixin in Japanese Healthy Elderly Male Subjects NCT03136380 | GlaxoSmithKline | Phase 1 |
| Unknown | Effect of Acupuncture on Patients With Chronic Obstructive Pulmonary Disease NCT03169504 | Henan University of Traditional Chinese Medicine | Phase 3 |
| Completed | OTIVACTO Spain Non Interventional Study NCT02927795 | Boehringer Ingelheim | — |
| Completed | Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD) NCT03034967 | GlaxoSmithKline | Phase 2 |
| Completed | NRS 2002 as a Predictor of Prognosis in COPD With Respiratory Failure NCT02942797 | West China Hospital | — |
| Completed | A Comparison of Three Nutritional Assessment Methods Predicting Prognosis in COPD With Respiratory Failure NCT02942784 | West China Hospital | — |
| Completed | Aerobic Interval Training in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Hypoxemia NCT03092622 | Norwegian University of Science and Technology | N/A |
| Completed | Cardiovascular Function in COPD Patients NCT03055988 | Boehringer Ingelheim | Phase 4 |
| Completed | The Effect of BEVESPI AEROSPHERE ® Therapy on Exercise Tolerance in COPD NCT03081156 | William Stringer, md | Phase 4 |
| Unknown | The Effect of Respiratory Training on Exercise Tolerance in COPD NCT04201522 | Laval University | N/A |
| Completed | A Cross-sectional Study on COPD Prevalence NCT03028207 | GlaxoSmithKline | — |
| Completed | Aclidinium Bromide Post-Authorisation Safety Study to Evaluate the Risk of Cardiovascular Endpoints NCT03290287 | AstraZeneca | — |
| Completed | COPD Discharge Bundle Delivered Alone or Enhanced Through a Care Coordinator NCT03358771 | University of Alberta | N/A |
| Completed | Ventilation and Pulmonary Endothelium Toxicities of E-cigarettes: A Randomized Crossover Pilot Study NCT02783768 | Columbia University | EARLY_Phase 1 |
| Completed | Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) in Chinese COPD Patients NCT02969317 | Boehringer Ingelheim | Phase 1 |
| Completed | FF/UMEC/VI Inhaler: Qualitative Analysis and Subject Preference Survey NCT03046069 | GlaxoSmithKline | — |
| Completed | Drug Utilization Study for Olodaterol NCT03030638 | Boehringer Ingelheim | — |
| Completed | Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mo NCT02668250 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Unknown | Effects of Upper-limb Training Addition to a Conventional ET Program on PA Level and ADL Performance. NCT03127878 | Universidade Estadual de Londrina | N/A |
| Unknown | The Gut-lung Axis in Chronic Obstructive Pulmonary Disease NCT03236480 | Peking University People's Hospital | — |
| Completed | Home COPD and Open Ventilation Evaluation (HOPE) Study NCT03691181 | Landon Pediatric Foundation | N/A |
| Completed | A Clinical Study Assessing Critical Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA® NCT02982187 | GlaxoSmithKline | Phase 4 |
| Completed | Vahelva Respimat Regulatory Post-marketing Surveillance in Korean Patients With Chronic Obstructive Pulmonary NCT02864407 | Boehringer Ingelheim | — |
| Completed | Study to Assess the Effect of the Aerobika Device in Addition to Standard of Care Treatment in Sputum Producin NCT02936817 | FLUIDDA nv | Phase 4 |
| Unknown | Effect of Traditional Chinese Medicine on Outcomes in COPD Patients NCT03007914 | Henan University of Traditional Chinese Medicine | — |
| Completed | Hepatitis C Virus(HCV) Heart and Lung Study NCT02858180 | Duke University | Phase 4 |
| Unknown | Registry of COPD Patients From Outpatient Polyclinic Healthcare Institutions of the Russian Federation in Mosc NCT02853383 | Interregional Public Organization, Russian Respiratory Society | — |
| Completed | Respiration Rate Monitoring in COPD Patients NCT03030313 | ResMed | N/A |
| Completed | Morphine for Treatment of Dyspnea in Patients With COPD NCT02429050 | Maastricht University Medical Center | Phase 4 |
| Unknown | Bronchial Infection in Patients With COPD and Frequent Exacerbations. NCT03259022 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | — |
| Completed | Effects of Dynamic Hyperinflation on the Left-ventricular Diastolic Function in Healthy Male Subjects NCT03500822 | Otto Wagner Hospital | N/A |
| Completed | Chronic Obstructive Pulmonary Disease Patient Preferences Survey NCT02970422 | McGill University | — |
| Completed | EVALUATION OF RESPIRATORY MECHANICS AND FUNCTIONALITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE NCT03086590 | Universidade Federal de Pernambuco | — |
| Completed | Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2269557 to Japanese Healthy Subjects NCT02972905 | GlaxoSmithKline | Phase 1 |
| Unknown | Evaluation of COPD Co-Pilot NCT02944591 | HGE Health Care Solutions, LLC | — |
| Unknown | Evaluate the Efficacy of Xuebijing Injection in Acute Exacerbations of COPD NCT02937974 | Chinese PLA General Hospital | Phase 4 |
| Terminated | Comparison of Walking in Water and on Land in People With Chronic Obstructive Pulmonary Disease (COPD) NCT02757157 | European Respiratory Society | N/A |
| Completed | Influenza Vaccination and COPD Phenotypes NCT02900209 | University of Lincoln | — |
| Completed | Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients NCT02853123 | Boehringer Ingelheim | Phase 4 |
| Completed | Advancing Symptom Alleviation With Palliative Treatment NCT02713347 | VA Office of Research and Development | N/A |
| Withdrawn | Magnesium Sulfate to Prevent Hospitalisation of Acute Exacerbations of Chronic Obstructive Pulmonary Disease NCT02498496 | Hôpital de Verdun | Phase 4 |
| Completed | A Phase I Pharmacokinetic Study of Fluticasone Furoate /Umeclidinium Bromide/Vilanterol (100/62.5/25 Microgram NCT02837380 | GlaxoSmithKline | Phase 1 |
| Completed | Impact of a Mobile Phone and Educational Intervention NCT06878898 | Kent State University | N/A |
| Terminated | Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With COPD (OTIVACTO) NCT02720757 | Boehringer Ingelheim | — |
| Completed | Long-term Use of Spiolto Respimat in Japanese Patients With Chronic Obstructive Pulmonary Disease NCT02850978 | Boehringer Ingelheim | — |
| Completed | SCCOR Minorities Observational Study NCT02898272 | University of Pittsburgh | — |
| Completed | Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonar NCT02700919 | Mereo BioPharma | Phase 2 |
| Completed | Corticosteroid Reduction in COPD NCT02857842 | Chronic Obstructive Pulmonary Disease Trial Network, Denmark | Phase 4 |
| Withdrawn | Telemedical Training for Chronically Ill COPD Patients: a Cross Sectoral Study NCT02754232 | Odense University Hospital | N/A |
| Unknown | Understanding Patient Management of COPD Exacerbations NCT02725294 | VA Puget Sound Health Care System | — |
| Active Not Recruiting | Personalized Prediction Strategy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease NCT03240315 | Guangzhou Institute of Respiratory Disease | — |
| Completed | An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients NCT02799784 | GlaxoSmithKline | Phase 4 |
| Completed | Right Heart Dysfunction and Pulmonary Hypertension Evaluation in Airway Disease Using Cardiac Magnetic Resonan NCT02865577 | University of Leicester | — |
| Enrolling By Invitation | The Cohort Study for Chronic Obstructive Pulmonary Disease (COPD) in China NCT03044847 | Beijing Chao Yang Hospital | — |
| Completed | Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versu NCT02729051 | GlaxoSmithKline | Phase 3 |
| Completed | Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstruct NCT02786927 | GlaxoSmithKline | Phase 4 |
| Withdrawn | A Study Comparing the Closed Triple Therapy, Open Triple Therapy and a Dual Therapy for Effect on Lung Functio NCT02731846 | GlaxoSmithKline | Phase 3 |
| Completed | Effect of Positive Airway Pressure Therapy on Hospitalization and Mortality in SDB Patients With Comorbid Chro NCT02923505 | Wissenschaftliches Institut Bethanien e.V | — |
| Completed | A 24 Week Efficacy Study of Inhaled Umeclidinium (UMEC) in Patients of Chronic Obstructive Pulmonary Disease ( NCT02184611 | GlaxoSmithKline | Phase 3 |
| Terminated | Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease NCT02587351 | University of Minnesota | Phase 3 |
| Completed | New Technology to Assess Treatment for Chronic Obstructive Pulmonary Disease (COPD) NCT02826343 | University of Virginia | EARLY_Phase 1 |
| Completed | Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic NCT02719184 | Boehringer Ingelheim | — |
| Unknown | Innate Immunity in Ozone-induced Airway Inflammation in COPD NCT04669743 | University of California, San Francisco | N/A |
| Unknown | Modified Dantien Salee Yoga Training Program in Chronic Obstructive Pulmonary Disease Rehabilitation NCT02770677 | Mahidol University | N/A |